- Cutaneous lymphomas are clonal proliferations of neoplastic T or B cells, rarely natural killer cells or plasmacytoid dendritic cells. Cutaneous lymphomas are the second most common group of extranodal lymphomas. The annual incidence is estimated to be 1 per 100,000.
- The WHO-EORTC classification is shown in Table 20-1.
- For rare conditions not dealt with in this Atlas the reader is referred to C Assaf, W Sterry, in K Wolff et al (eds): Fitzpatrick's Dermatology in General Medicine, 7th ed. New York, McGraw-Hill, 2008, pp 1386–1402.
Table 20-1 WHO-EORTC Classification of Primary Cutaneous Lymphomas |Favorite Table|Download (.pdf)
Table 20-1 WHO-EORTC Classification of Primary Cutaneous Lymphomas
Cutaneous T-Cell and NK-Cell Lymphomas
- Mycosis fungoides
- Mycosis fungoides variants and sub-types
- Folliculotropic mycosis fungoides
- Pagetoid reticulosis
- Granulomatous slack skin
- Sézary syndrome
- Adult T-cell leukemia/lymphoma
- Primary cutaneous CD30-positive lymphop roliferative disorders
- Primary cutaneous anaplastic large-cell lymphoma
- Lymphomatoid papulosis
- Subcutaneous panniculitis-like T-cell lymphoma
- Extra-nodal NK/T-cell lymphoma, nasal type
- Provisional entities of cutaneous T-cell lymphoma
- Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma
- Cutaneous γ/δ T-cell lymphoma
- Primary cutaneous CD4+ small or medium-sized pleomorphic T-cell lymphoma
Cutaneous B-Cell Lymphomas
- Primary cutaneous marginal zone B-cell lymphoma
- Primary cutaneous follicle center lymphoma
- Primary cutaneous diffuse lagre B-cell lymphoma, leg type
- Primary cutaneous diffuse large B-cell lymphoma, other
- Intravascular large B-cell lymphoma (provisional)
- Precursor hematologic neoplasm
- CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma)
ICD-9 : 204.0/208.9 • ICD-10 : C83/E88
- Adult T cell leukemia/lymphoma (ATLL) is a neoplasm of CD4+/CD25+ T cells, caused by human T cell lymphotrophic virus I (HTLV-I).
- Manifested by skin infiltrates, hypercalcemia, visceral involvement, lytic bone lesions, and abnormal lymphocytes on peripheral smears.
- HTLV-I is a human retrovirus. Infection by the virus does not usually cause disease, which suggests that other environmental factors are involved. Immortalization of some infected CD4+ T cells, increased mitotic activity, genetic instability, and impairment of cellular immunity can all occur after infection with HTLV-I. These events may increase the probability of additional genetic changes, which, by chance, may lead to the development of leukemia 20–40 years after infection in some people (≤5%). Most of these effects have been attributed to the HTLV-I-encoded protein tax.
- ATLL occurs in southwestern Japan (Kyushu), Africa, the Caribbean Islands, southeastern United States. Transmission is by sexual intercourse, perinatally, or by exposure to blood or blood products (same as HIV).
- There are four main categories. In the relatively indolent smoldering and chronic forms, the median survival is ≥2 years. In the acute and lymphomatous forms, it ranges from only 4–6 months.
- Symptoms include fever, weight loss, abdominal pain, diarrhea, pleural effusion, ascites, cough, sputum. Skin lesions occur in 50% of patients with ATLL. Single to multiple small, confluent erythematous, violaceous papules (Fig. 20-1), ±purpura; firm violaceous to brownish nodules (Fig. 20-2); papulosquamous lesions, ...
Log In to View More
If you don't have a subscription, please view our individual subscription options below to find out how you can gain access to this content.
Want remote access to your institution's subscription?
Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.
If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.
AccessEmergency Medicine Full Site: One-Year Subscription
Connect to the full suite of AccessEmergency Medicine content and resources including advanced 8th edition chapters of Tintinalli’s, high-quality procedural videos and images, interactive board review, an integrated drug database, and more.
Pay Per View: Timed Access to all of AccessEmergency Medicine
24 Hour Subscription $34.95
48 Hour Subscription $54.95
Pop-up div Successfully Displayed
This div only appears when the trigger link is hovered over.
Otherwise it is hidden from view.